Related Experiment Video
Updated: Oct 13, 2025

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
miR-25 Regulates Gastric Cancer Cell Growth and Apoptosis by Targeting EGR2
Liuqing Yang1, Lina Li2, Pan Chang1
1Second Affiliated Hospital of Xi'an Medical University, Xi' an, China.
Abstract:
Gastric cancer is one of the most common malignancies harmful to human health. The search for effective drugs or gene therapy has aroused the attention of scientists. So far, microRNAs, as small non-coding RNAs, have the potential to be therapeutic targets for cancer. Herein, we found a highly expressed miR-25 in gastric cancer cell. However, the function of miR-25 for gastric cancer cell growth and apoptosis was unknown. Functionally, we used RT-qPCR, western blot, CCK-8, and flow cytometry to detect gastric cancer cell growth and apoptosis. The results indicated that miR-25 promoted gastric cancer cell growth and inhibited their apoptosis. Mechanistically, we found that a gene EGR2 was a potential target gene of miR-25. Further dual-luciferase results supported this prediction. Moreover, knockdown of EGR2 promoted gastric cancer cell growth and inhibited their apoptosis by flow cytometry detection. Altogether, these findings revealed miR-25 as a regulator of gastric cancer cell growth and apoptosis through targeting EGR2.
Insights
MicroRNA-25 (miR-25) promotes gastric cancer cell growth and inhibits apoptosis. This study reveals miR-25 targets EGR2, highlighting a potential therapeutic pathway for gastric cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer is a leading cause of cancer-related mortality worldwide.
- MicroRNAs (miRNAs) are implicated in various cancers, including gastric cancer.
- The specific role of miR-25 in gastric cancer progression remained largely uncharacterized.
Purpose of the Study:
- To investigate the functional role of miR-25 in gastric cancer cell growth and apoptosis.
- To elucidate the underlying molecular mechanism of miR-25 action in gastric cancer.
- To identify potential therapeutic targets for gastric cancer treatment.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) to measure miR-25 expression.
- Western blot analysis to assess protein levels.
- Cell Counting Kit-8 (CCK-8) assay for cell proliferation.
- Flow cytometry to evaluate apoptosis.
- Dual-luciferase reporter assay to validate target gene interaction.
Main Results:
- miR-25 was found to be highly expressed in gastric cancer cells.
- Overexpression of miR-25 significantly promoted gastric cancer cell proliferation and suppressed apoptosis.
- EGR2 was identified as a direct target gene of miR-25.
- Knockdown of EGR2 mimicked the pro-proliferative and anti-apoptotic effects of miR-25.
Conclusions:
- miR-25 acts as an oncogenic microRNA in gastric cancer.
- miR-25 promotes gastric cancer cell growth and inhibits apoptosis by targeting the EGR2 gene.
- Targeting the miR-25/EGR2 axis presents a potential therapeutic strategy for gastric cancer.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Related Concept Videos
Mitogens and the Cell Cycle
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...